Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort

References

• Khorana AA, Francis CW, Culakova E, et al. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer. 2007;110:2339–2346.
   PubMed Web of Science ®Google Scholar
• Khorana A, Francis C, Culakova E, et al. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost. 2007;5:632–634.
   PubMed Web of Science ®Google Scholar
• Kopolovic I, Lee AY, Wu C. Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study. Ann Hematol. 2015;94:329–336.
   PubMed Web of Science ®Google Scholar
• Prandoni P, Lensing AWA, Piccioli A, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood. 2002;100:3484–3488.
   PubMed Web of Science ®Google Scholar
• Labrador J, Lopez-Anglada L, Perez-Lopez E, et al. Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients. Haematologica. 2013;98:437–443.
   PubMed Web of Science ®Google Scholar
• Drakos PE, Nagler A, Or R, et al. Low molecular weight heparin for hickman catheter‐induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation. Cancer. 1992;70:1895–1898.
   PubMed Web of Science ®Google Scholar
• Herishanu Y, Misgav M, Kirgner I, et al. Enoxaparin can be used safely in patients with severe thrombocytopenia due to intensive chemotherapy regimens. Leuk Lymphoma. 2004;45:1407–1411.
   PubMed Web of Science ®Google Scholar
• Campbell PM, Ippoliti C, Parmar S. Safety of anticoagulation in thrombocytopenic patients with hematologic malignancies: a case series. J Oncol Pharm Pract. 2017;23:220–225.
   PubMed Web of Science ®Google Scholar
• Carrier M, Khorana AA, Zwicker J, Malignancy for the SSCotI, et al. Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH. J Thromb Haemost. 2013;11:1760–1765.
   PubMed Web of Science ®Google Scholar
• Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. CHEST J. 2012;141:419–494.
   Web of Science ®Google Scholar
• Lyman GH, Khorana AA, Falanga A, American Society of Clinical O, et al. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. JCO. 2007;25:5490–5505.
   PubMed Web of Science ®Google Scholar
• Mandala M, Falanga A, Roila F, et al. Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2011;22:85–92.
   Web of Science ®Google Scholar
• Farge D, Debourdeau P, Beckers M, et al. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost. 2013;11:56–70.
   PubMed Web of Science ®Google Scholar
• Easaw JC, Shea-Budgell MA, Wu CMJ, et al. Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment. Curr Oncol. 2015;22:144–155.
   PubMed Web of Science ®Google Scholar
• Elice F, Rodeghiero F. Hematologic malignancies and thrombosis. Thromb Res. 2012;129:360–366.
   PubMed Web of Science ®Google Scholar
• De Stefano V, Sora F, Rossi E, et al. The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment. J Thromb Haemost. 2005;3:1985–1992.
   PubMed Web of Science ®Google Scholar
• Kaufman RM, Djulbegovic B, Gernsheimer T, et al. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2015;162:205–213.
   PubMed Web of Science ®Google Scholar
• Stanworth SJ, Estcourt LJ, Powter G, et al. A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med. 2013;368:1771–1780.
   PubMed Web of Science ®Google Scholar
• Gerber DE, Segal JB, Levy MY, et al. The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention. Blood. 2008;112:504–510.
   PubMed Web of Science ®Google Scholar
• Lim M, Enjeti AK. Safety of anticoagulation in the treatment of venous thromboembolism in patients with haematological malignancies and thrombocytopenia: report of 5 cases and literature review. Crit Rev Oncol/Hematol. 2016;105:92–99.
   PubMed Web of Science ®Google Scholar
• Ibrahim RB, Skewes MD, Kuriakose P. ‘Sailing in troubled waters’: a review of the use of anticoagulation in adult cancer patients with thrombocytopenia. Blood Coagul Fibrinolysis. 2016;27:615.
   PubMed Web of Science ®Google Scholar
• Webert KE, Arnold DM, Lui Y, et al. A new tool to assess bleeding severity in patients with chemotherapy-induced thrombocytopenia. Transfusion. 2012;52:2466–2474.
   PubMed Web of Science ®Google Scholar
• Samuelson BT, Gernsheimer T, Estey E, et al. Variability in management of hematologic malignancy patients with venous thromboembolism and chemotherapy-induced thrombocytopenia. Thromb Res. 2016;141:104–105.
   PubMed Web of Science ®Google Scholar
• Khanal N, Bociek RG, Chen B, et al. Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia. Am J Hematol. 2016;91:E468–E472.
   PubMed Web of Science ®Google Scholar
• Oliver N, Short B, Thein M, et al. Treatment of catheter-related deep vein thrombosis in patients with acute leukemia with anticoagulation. Leuk Lymphoma. 2015;56:2082–2086.
   PubMed Web of Science ®Google Scholar
• Napolitano M, Valore L, Malato A, et al. Management of venous thromboembolism in patients with acute leukemia at high bleeding risk: a multi-center study. Leuk Lymphoma. 2015;57:116–119.
   PubMed Web of Science ®Google Scholar
• Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. JCO. 2003;21:3665–3675.
   PubMed Web of Science ®Google Scholar
• Winters JP, Callas PW, Cushman M, et al. Central venous catheters and upper extremity deep vein thrombosis in medical inpatients: the Medical Inpatients and Thrombosis (MITH) Study. J Thromb Haemost. 2015;13:2155–2160.
   PubMed Web of Science ®Google Scholar
• Debourdeau P, Farge D, Beckers M. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost 2013;11:71–80.
   PubMed Web of Science ®Google Scholar
• Babilonia KM, Golightly LK, Gutman JA, et al. Antithrombotic therapy in patients with thrombocytopenic cancer: outcomes associated with reduced-dose, low-molecular-weight heparin during hospitalization. Clin Appl Thromb Hemost. 2014;20:799–806.
   PubMed Web of Science ®Google Scholar
• Ibrahim RB, Peres E, Dansey R, et al. Safety of low-dose low-molecular-weight-heparins in thrombocytopenic stem cell transplantation patients: a case series and review of the literature. Bone Marrow Transplant. 2005;35:1071–1077.
   PubMed Web of Science ®Google Scholar
• Eikenboom JCJ, van Wordragen R, Brand A. Compliance with prophylactic platelet transfusion trigger in haematological patients. Transfus Med. 2005;15:45–48.
   PubMed Web of Science ®Google Scholar
• Falanga A, Marchetti M, Vignoli A. Coagulation and cancer: biological and clinical aspects. J Thromb Haemost. 2013;11:223–233.
   PubMed Web of Science ®Google Scholar
• Franchini M, Frattini F, Crestani S, et al. Bleeding complications in patients with hematologic malignancies. Semin Thromb Hemost. 2012;39:94–100.
   PubMed Web of Science ®Google Scholar
• Libourel EJ, Klerk C, Norden Y, et al. Disseminated intravascular coagulation at diagnosis is a strong predictor for both arterial and venous thrombosis in newly diagnosed acute myeloid leukemia. Blood. 2016;128:1854–1861.
   PubMed Web of Science ®Google Scholar